HK1259196A1 - 延遲釋放製劑、其製備方法和用途 - Google Patents
延遲釋放製劑、其製備方法和用途Info
- Publication number
- HK1259196A1 HK1259196A1 HK19101249.6A HK19101249A HK1259196A1 HK 1259196 A1 HK1259196 A1 HK 1259196A1 HK 19101249 A HK19101249 A HK 19101249A HK 1259196 A1 HK1259196 A1 HK 1259196A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- delayed
- making
- methods
- release formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/842,539 US10278925B2 (en) | 2012-01-04 | 2015-09-01 | Delayed-release formulations, methods of making and use thereof |
PCT/US2016/041354 WO2017039833A1 (en) | 2015-09-01 | 2016-07-07 | Delayed-release formulations, methods of making and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1259196A1 true HK1259196A1 (zh) | 2019-11-29 |
Family
ID=58188685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK19101249.6A HK1259196A1 (zh) | 2015-09-01 | 2019-01-24 | 延遲釋放製劑、其製備方法和用途 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP3344241A4 (zh) |
JP (1) | JP2018526442A (zh) |
KR (1) | KR20180054656A (zh) |
CN (1) | CN108348487A (zh) |
AU (1) | AU2016317093A1 (zh) |
HK (1) | HK1259196A1 (zh) |
MX (1) | MX2018002449A (zh) |
RU (1) | RU2018111401A (zh) |
SG (1) | SG11201805812QA (zh) |
WO (1) | WO2017039833A1 (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1758904A (zh) * | 2003-03-21 | 2006-04-12 | 麦克内尔-Ppc股份有限公司 | 非甾体抗炎药物的给药方案 |
US20150010599A1 (en) * | 2010-07-08 | 2015-01-08 | WELLESLEY PHARMACELJTlCALS, LLC | Pharmaceutical formulation for reducing bladder spasms and method of use thereof |
US20120237574A1 (en) * | 2010-07-08 | 2012-09-20 | Wellesley Pharmaceuticals, Llc | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
US9415048B2 (en) * | 2010-07-08 | 2016-08-16 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
WO2013103389A1 (en) * | 2012-01-04 | 2013-07-11 | Wellesley Pharmaceuticals, Llc | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
KR20140108675A (ko) * | 2012-01-04 | 2014-09-12 | 웰즐리 파마슈티컬스 엘엘씨 | 배뇨 빈도를 감소시키기 위한 연장-방출형 제제 및 이의 사용 방법 |
CN103191430A (zh) * | 2012-01-04 | 2013-07-10 | 韦尔斯利医药有限公司 | 用于缓解尿频的缓释制剂及其使用方法 |
-
2016
- 2016-07-07 SG SG11201805812QA patent/SG11201805812QA/en unknown
- 2016-07-07 MX MX2018002449A patent/MX2018002449A/es unknown
- 2016-07-07 CN CN201680050660.8A patent/CN108348487A/zh active Pending
- 2016-07-07 JP JP2018530487A patent/JP2018526442A/ja active Pending
- 2016-07-07 EP EP16842483.6A patent/EP3344241A4/en not_active Withdrawn
- 2016-07-07 AU AU2016317093A patent/AU2016317093A1/en not_active Abandoned
- 2016-07-07 RU RU2018111401A patent/RU2018111401A/ru not_active Application Discontinuation
- 2016-07-07 WO PCT/US2016/041354 patent/WO2017039833A1/en active Application Filing
- 2016-07-07 KR KR1020187009153A patent/KR20180054656A/ko unknown
-
2019
- 2019-01-24 HK HK19101249.6A patent/HK1259196A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20180054656A (ko) | 2018-05-24 |
WO2017039833A1 (en) | 2017-03-09 |
MX2018002449A (es) | 2018-08-24 |
RU2018111401A (ru) | 2019-10-02 |
EP3344241A4 (en) | 2019-04-03 |
SG11201805812QA (en) | 2018-08-30 |
AU2016317093A1 (en) | 2018-04-26 |
EP3344241A1 (en) | 2018-07-11 |
CN108348487A (zh) | 2018-07-31 |
JP2018526442A (ja) | 2018-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254525A1 (zh) | 治療組合物、組合和使用方法 | |
IL286316A (en) | New micro-dystrophins and related method of use | |
IL272306B (en) | Pridopidine analogues, their preparation and use | |
HK1232140A1 (zh) | 微類器官以及製造和使用它們的方法 | |
ZA201805805B (en) | Formulations and methods | |
IL259246A (en) | Preparations containing pharmaceutical substances and methods of using them | |
HK1259372A1 (zh) | 治療化合物、其組合物及使用方法 | |
SG11201609254YA (en) | Therapeutic placental compositions, methods of making and methods of use | |
GB201519128D0 (en) | Solid forms and methods of preparing the same | |
EP3373910C0 (en) | FORMULATION OF ECHINOMYCIN, METHOD OF MANUFACTURING AND METHOD OF USE THEREOF | |
PT3534743T (pt) | Calçado, e método de preparar o mesmo | |
FI3380525T3 (fi) | Lääkeformulaatioita ja niiden käyttömenetelmiä | |
IL258139A (en) | Nicotine compositions and methods for their preparation and use | |
IL254783B (en) | Combinations for deworming methods for using them | |
HK1249068A1 (zh) | 小檗碱製劑的治療用途 | |
PL2998311T3 (pl) | Mieszanina alkiloglikozydów, ich wytwarzanie i zastosowanie | |
IL272857A (en) | Cofanalisib formulations | |
ZA201906326B (en) | Analogs of deutetrabenazine, their preparation and use | |
HK1258765A1 (zh) | 治療性化合物、組合物和它們的使用方法 | |
GB201603591D0 (en) | Improved promotors and compositions | |
GB201518791D0 (en) | Descender | |
PT3678644T (pt) | Formulações de copanlisib | |
HK1259196A1 (zh) | 延遲釋放製劑、其製備方法和用途 |